Table 5. Associations between regional cerebrovascular disease and regional amyloid uptake measured as PET SUVR for CHE, SCD and MCI subjects.
Group | Parameter | ARWMC frontal | ARWMC parito-occipital | ARWMC temporal | ||||||
---|---|---|---|---|---|---|---|---|---|---|
CHE, SCD, MCI | Frontal SUVR | 0.088 | −0.027 | 0.203 | 0.079 | −0.036 | 0.194 | 0.140* | 0.022 | 0.259 |
Parietal SUVR | 0.119 | 0.004 | 0.233 | 0.117 | 0.002 | 0.231 | 0.168** | 0.050 | 0.285 | |
Occipital SUVR | 0.097 | −0.018 | 0.213 | 0.092 | −0.023 | 0.207 | 0.148* | 0.029 | 0.266 | |
Temporal SUVR | 0.061 | −0.053 | 0.175 | 0.055 | −0.059 | 0.168 | 0.104 | −0.014 | 0.221 |
Values represent standardized beta from linear regression with regional ARWMC as dependent and regional amyloid uptake as independent variable as well as the confidence intervals, and are corrected for age, sex and hippocampal volume. Cerebrovascular disease was estimated as the total score of white matter lesion rating according to the ARWMC scale, total sum, and regional, mean of left and right. PET SUVR was estimated the regional uptake, mean of left and right; the natural logarithm of PET estimates was used.
*p < 0.05, **p < 0.0125, ***p > 0.001.
Only p-values < 0.0125 should be considered significant according to Bonferroni-adjustment.